Molecular pathways of oral submucous fibrosis and its progression to malignancy

K Gayathri, N Malathi, V Gayathri, PN Adtani… - Archives of oral …, 2023 - Elsevier
Objective The review aims to comprehend various factors engaged in the alteration of
molecular events resulting in Oral submucous fibrosis (OSMF) and its malignant …

Genetic susceptibility and protein expression of extracellular matrix turnover-related genes in oral submucous fibrosis

RH Cheng, YP Wang, JYF Chang, YH Pan… - International journal of …, 2020 - mdpi.com
Betel quid (BQ) chewing increased the risk of oral cancer and oral submucous fibrosis
(OSMF), an oral premalignant disorder (OPMD) with malignant transformation potential. BQ …

Exploring Possible Diagnostic Precancerous Biomarkers for Oral Submucous Fibrosis: A Narrative Review

JR You, YT Chen, CY Hsieh, SY Chen, TY Lin, JS Shih… - Cancers, 2023 - mdpi.com
Simple Summary Oral submucous fibrosis is a progressive oral disorder categorized as a
potentially malignant condition. Researchers have identified specific molecular biomarkers …

[HTML][HTML] Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma

AR Gadbail, SC Sarode, MS Chaudhary… - Journal of Applied Oral …, 2021 - SciELO Brasil
Abstract Objective To investigate the Ki 67 expression and its correlation with
clinicopathological features and 3 years as well as 5 years survival rate in oral squamous …

Mechanisms and markers of malignant transformation of oral submucous fibrosis

F Lin, T Xiao, B Wang, L Wang, G Liu, R Wang, C Xie… - Heliyon, 2024 - cell.com
Oral submucous fibrosis (OSF) is a chronic premalignant disease associated with betel quid
chewing. Epidemiological studies indicate that there are approximately 5 million individuals …

[HTML][HTML] Ki67, CD105, and α-SMA expression supports biological distinctness of oral squamous cell carcinoma arising in the background of oral submucous fibrosis

AR Gadbail, S Korde, MS Chaudhary… - Asian Pacific Journal …, 2020 - ncbi.nlm.nih.gov
Background: The clinicopathological distinctness of oral squamous cell carcinoma arising in
the background of oral submucous fibrosis (OSCC-OSF) is well known; however, the …

Immunohistochemical biomarkers in oral submucous fibrosis: A scoping review

L Kavitha, K Ranganathan, S Shyam… - Journal of Oral …, 2022 - Wiley Online Library
Introduction This scoping review was done to study the immunohistochemical biomarkers
involved in the pathogenesis and malignant transformation of oral submucous fibrosis …

Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma—A …

D Mohapatra, S Panda, N Mohanty, S Panda… - International Journal of …, 2023 - mdpi.com
The objective of the study was to compare the expression of immunohistochemical (IHC)
markers of oral submucous fibrosis (OSMF)(non-transformed group) to those of oral …

Nesfatin-1 is a potential diagnostic biomarker for gastric cancer

XQ Wang, Y Zheng, PF Fang… - Oncology …, 2020 - spandidos-publications.com
The lack of reliable plasma biomarkers limits their use in the diagnosis of gastric cancer
(GC). The current study aimed to determine whether plasma nesfatin-1 can be used as a …

[HTML][HTML] Diagnostic utility of cytokeratin 17 expression in oral squamous cell carcinoma: a review

A Gyanchandani, S Shukla, S Vagha, S Acharaya… - Cureus, 2022 - ncbi.nlm.nih.gov
One of the most common oral malignancies is oral squamous cell carcinoma (OSCC).
Although the prevalence of oral cancer varies worldwide, it is generally agreed that the oral …